EQUITY (Tables)
|
12 Months Ended |
Dec. 31, 2025 |
|---|
| Equity [Abstract] |
|
| Reconciliation Of Common Stock Issued |
The following table reconciles common stock reported in the consolidated statements of changes in equity to the consolidated balance sheets.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, |
|
|
2025 |
|
2024 |
| Common shares issued as reported in the consolidated statement of changes in equity |
|
232,837,623 |
|
|
231,295,639 |
|
|
|
|
|
|
| Unvested restricted stock awards |
|
1,402,205 |
|
|
1,480,062 |
|
| Unvested deferred stock awards |
|
1,755,749 |
|
|
1,996,058 |
|
| Common shares issued as reported in the consolidated balance sheets |
|
235,995,577 |
|
|
234,771,759 |
|
|
| Change in Noncontrolling Ownership Interest |
The following schedule reflects the change in ownership interests for these transactions:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Year Ended December 31, |
| |
2025 |
|
2024 |
|
2023 |
| |
(in thousands) |
Net income attributable to common stockholders of Live Nation |
$ |
495,972 |
|
|
$ |
896,287 |
|
|
$ |
556,893 |
|
| Transfers of noncontrolling interests: |
|
|
|
|
|
Changes in Live Nation’s additional paid-in capital for purchases of noncontrolling interests, net of transaction costs |
(32,435) |
|
|
(30,049) |
|
|
(100,940) |
|
|
|
|
|
|
|
| Net transfers of noncontrolling interests |
(32,435) |
|
|
(30,049) |
|
|
(100,940) |
|
Change from net income attributable to common stockholders of Live Nation and net transfers of noncontrolling interests |
$ |
463,537 |
|
|
$ |
866,238 |
|
|
$ |
455,953 |
|
|
| Schedule of Accumulated Other Comprehensive Income (Loss) |
The following table presents changes in the components of AOCI, net of taxes, for the years ended December 31, 2025, 2024 and 2023:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash Flow Hedges |
|
|
|
Cumulative Foreign Currency Translation Adjustments |
|
|
|
Total |
|
|
(in thousands) |
| Balance at December 31, 2022 |
|
$ |
41,283 |
|
|
|
|
$ |
(131,359) |
|
|
|
|
$ |
(90,076) |
|
| Other comprehensive income before reclassifications |
|
5,225 |
|
|
|
|
129,459 |
|
|
|
|
134,684 |
|
| Amount reclassified from AOCI |
|
(17,158) |
|
|
|
|
— |
|
|
|
|
(17,158) |
|
| Net other comprehensive income (loss) |
|
(11,933) |
|
|
|
|
129,459 |
|
|
|
|
117,526 |
|
| Balance at December 31, 2023 |
|
29,350 |
|
|
|
|
(1,900) |
|
|
|
|
27,450 |
|
| Other comprehensive income (loss) before reclassifications |
|
10,529 |
|
|
|
|
(354,730) |
|
|
|
|
(344,201) |
|
| Amount reclassified from AOCI |
|
(18,361) |
|
|
|
|
— |
|
|
|
|
(18,361) |
|
| Net other comprehensive loss |
|
(7,832) |
|
|
|
|
(354,730) |
|
|
|
|
(362,562) |
|
| Balance at December 31, 2024 |
|
21,518 |
|
|
|
|
(356,630) |
|
|
|
|
(335,112) |
|
| Other comprehensive income (loss) before reclassifications |
|
(820) |
|
|
|
|
237,886 |
|
|
|
|
237,066 |
|
| Amount reclassified from AOCI |
|
(16,826) |
|
|
|
|
— |
|
|
|
|
(16,826) |
|
| Net other comprehensive income (loss) |
|
(17,646) |
|
|
|
|
237,886 |
|
|
|
|
220,240 |
|
| Balance at December 31, 2025 |
|
$ |
3,872 |
|
|
|
|
$ |
(118,744) |
|
|
|
|
$ |
(114,872) |
|
|
| Computation of Weighted Average Common Shares Outstanding |
The following table sets forth the computation of weighted average common shares outstanding:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31, |
|
|
2025 |
|
2024 |
|
2023 |
| Weighted average common shares—basic |
|
231,844,300 |
|
|
230,124,255 |
|
|
228,628,390 |
|
| Effect of dilutive shares: |
|
|
|
|
|
|
| Stock options and restricted stock |
|
— |
|
|
2,686,001 |
|
|
2,348,936 |
|
| Convertible senior notes |
|
— |
|
|
3,542,193 |
|
|
— |
|
| Weighted average common shares—diluted |
|
231,844,300 |
|
|
236,352,449 |
|
|
230,977,326 |
|
|
| Potentially Dilutive Securities Excluded From Diluted Net Income Per Common Share |
The following table shows securities excluded from the calculation of diluted net income per common share because such securities were anti-dilutive:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31, |
|
|
2025 |
|
2024 |
|
2023 |
| Options to purchase shares of common stock |
|
924,602 |
|
|
— |
|
|
3,750 |
|
| Restricted and deferred stock awards—unvested |
|
3,086,132 |
|
|
1,518,940 |
|
|
2,527,463 |
|
|
|
|
|
|
|
|
Conversion shares related to convertible senior notes |
|
21,170,322 |
|
|
14,946,450 |
|
|
13,004,660 |
|
Number of anti-dilutive potentially issuable shares excluded from diluted common shares outstanding |
|
25,181,056 |
|
|
16,465,390 |
|
|
15,535,873 |
|
|